How do we get there from where we are now? GOLD perspective

A. Agusti Garcia-Navarro (Barcelona, Spain)

Source: International Congress 2017 – The Lancet commission on asthma
Session: The Lancet commission on asthma
Session type: Session
Number: 4393
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Agusti Garcia-Navarro (Barcelona, Spain). How do we get there from where we are now? GOLD perspective. International Congress 2017 – The Lancet commission on asthma

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Implementing the BTS COPD guidelines: how far have we come?
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002

Management of stable COPD: Are GOLD recommendations fully applied?
Source: Annual Congress 2010 - COPD: management
Year: 2010


Definition of COPD: based on evidence or opinion?
Source: Eur Respir J 2008; 31: 681-682
Year: 2008


Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?
Source: Eur Respir J 2014; 43: 1201-1203
Year: 2014


The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


GOLD 2011 versus GOLD 2017 – What does change?
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Precision medicine in COPD: where are we and where do we need to go?
Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018
Year: 2018



The distribution of COPD in UK general practice using the new GOLD classification
Source: Eur Respir J 2014; 43: 993-1002
Year: 2014



New GOLD 2011 guidelines: Is there an improvement?
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


Chronic obstructive pulmonary disease: How good is GOLD on its own?!
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013

"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

An old disease from a new perspective – GOLD 2011 recommendations for COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012

Hard talk: is GINA truly global? Successes and challenges
Source: International Congress 2018 – GINA 2018 and beyond: shaping the future of asthma management
Year: 2018


Rethinking COPD Exacerbations: a global patient perspective
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021


The distribution of COPD in UK general practice using the 2017 GOLD classification
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


What's new in the management of CAP?
Source: Annual Congress 2012 - New guidelines in respiratory infections
Year: 2012


FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
Source: Eur Respir J 2013; 42: 1391-1401
Year: 2013